Shepard RL[au] - Search Results

Year	Number of Results
1987	1
1989	1
1994	2
1996	1
1997	1
1998	1
1999	3
2001	1
2002	4
2003	2
2004	1
2005	2
2012	1
2013	3
2015	1
2023	0

1

Three-dimensional quantitative structure-activity relationships of inhibitors of P-glycoprotein.

Ekins S, Kim RB, Leake BF, Dantzig AH, Schuetz EG, Lan LB, Yasuda K, Shepard RL, Winter MA, Schuetz JD, Wikel JH, Wrighton SA. Ekins S, et al. Among authors: shepard rl. Mol Pharmacol. 2002 May;61(5):964-73. doi: 10.1124/mol.61.5.964. Mol Pharmacol. 2002. PMID: 11961113

2

Pharmacological characterization of LY335979: a potent cyclopropyldibenzosuberane modulator of P-glycoprotein.

Starling JJ, Shepard RL, Cao J, Law KL, Norman BH, Kroin JS, Ehlhardt WJ, Baughman TM, Winter MA, Bell MG, Shih C, Gruber J, Elmquist WF, Dantzig AH. Starling JJ, et al. Among authors: shepard rl. Adv Enzyme Regul. 1997;37:335-47. doi: 10.1016/s0065-2571(96)00021-0. Adv Enzyme Regul. 1997. PMID: 9381979

3

The role of ammonia toxicity in the post transurethral prostatectomy syndrome.

Shepard RL, Kraus SE, Babayan RK, Siroky MB. Shepard RL, et al. Br J Urol. 1987 Oct;60(4):349-51. doi: 10.1111/j.1464-410x.1987.tb04983.x. Br J Urol. 1987. PMID: 3690208

4

Bioavailability to rats of iron from fortified grain amaranth.

Ologunde MO, Morris JB, Shepard RL, Afolabi AO, Oke OL. Ologunde MO, et al. Among authors: shepard rl. Plant Foods Hum Nutr. 1994 Apr;45(3):191-201. doi: 10.1007/BF01094089. Plant Foods Hum Nutr. 1994. PMID: 8052576

5

Association of intestinal peptide transport with a protein related to the cadherin superfamily.

Dantzig AH, Hoskins JA, Tabas LB, Bright S, Shepard RL, Jenkins IL, Duckworth DC, Sportsman JR, Mackensen D, Rosteck PR Jr, et al. Dantzig AH, et al. Among authors: shepard rl. Science. 1994 Apr 15;264(5157):430-3. doi: 10.1126/science.8153632. Science. 1994. PMID: 8153632

6

Human carboxylesterase-2 hydrolyzes the prodrug of gemcitabine (LY2334737) and confers prodrug sensitivity to cancer cells.

Pratt SE, Durland-Busbice S, Shepard RL, Heinz-Taheny K, Iversen PW, Dantzig AH. Pratt SE, et al. Among authors: shepard rl. Clin Cancer Res. 2013 Mar 1;19(5):1159-68. doi: 10.1158/1078-0432.CCR-12-1184. Epub 2013 Jan 16. Clin Cancer Res. 2013. PMID: 23325581

7

Modulation of P-glycoprotein but not MRP1- or BCRP-mediated drug resistance by LY335979.

Shepard RL, Cao J, Starling JJ, Dantzig AH. Shepard RL, et al. Int J Cancer. 2003 Jan 1;103(1):121-5. doi: 10.1002/ijc.10792. Int J Cancer. 2003. PMID: 12455064 Free article.

8

Application of three-dimensional quantitative structure-activity relationships of P-glycoprotein inhibitors and substrates.

Ekins S, Kim RB, Leake BF, Dantzig AH, Schuetz EG, Lan LB, Yasuda K, Shepard RL, Winter MA, Schuetz JD, Wikel JH, Wrighton SA. Ekins S, et al. Among authors: shepard rl. Mol Pharmacol. 2002 May;61(5):974-81. doi: 10.1124/mol.61.5.974. Mol Pharmacol. 2002. PMID: 11961114

9

Reversal of P-glycoprotein-mediated multidrug resistance by a potent cyclopropyldibenzosuberane modulator, LY335979.

Dantzig AH, Shepard RL, Cao J, Law KL, Ehlhardt WJ, Baughman TM, Bumol TF, Starling JJ. Dantzig AH, et al. Among authors: shepard rl. Cancer Res. 1996 Sep 15;56(18):4171-9. Cancer Res. 1996. PMID: 8797588

10

Efficacy of low-dose oral metronomic dosing of the prodrug of gemcitabine, LY2334737, in human tumor xenografts.

Pratt SE, Durland-Busbice S, Shepard RL, Donoho GP, Starling JJ, Wickremsinhe ER, Perkins EJ, Dantzig AH. Pratt SE, et al. Among authors: shepard rl. Mol Cancer Ther. 2013 Apr;12(4):481-90. doi: 10.1158/1535-7163.MCT-12-0654. Epub 2013 Jan 31. Mol Cancer Ther. 2013. PMID: 23371859

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results